SCHEMBL2478043

SCHEMBL2478043

NNC(=O)[C@H]1CC[C@@H](Oc2ccccn2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.46
AVPR1A P37288 6/20 0.46
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
LMNA P02545 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HCRTR1 O43613 1/20 0.42
HCRTR2 O43614 1/20 0.42
MAPT P10636 2/20 0.41
TNKS O95271 2/20 0.41
PARP2 Q9UGN5 2/20 0.41
PARP1 P09874 1/20 0.41
FURIN P09958 1/20 0.40
ALDH1A1 P00352 3/20 0.40
TP53 P04637 1/20 0.40
PKM P14618 1/20 0.40
IP6K1 Q92551 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
ADORA3 P0DMS8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29500834 1.00 EPHX2 (0.46) EPHX2AVPR1ARAB9ANPC1LMNA
SCHEMBL2473976 1.00 EPHX2 (0.46) EPHX2AVPR1ARAB9ANPC1LMNA
SCHEMBL16801961 1.00 EPHX2 (0.46) EPHX2AVPR1ARAB9ANPC1LMNA
SCHEMBL2473973 1.00 EPHX2 (0.46) EPHX2AVPR1ARAB9ANPC1LMNA
Isothiocyanate SCHEMBL25200910 0.93 AVPR1A (0.42) EPHX2AVPR1ARAB9ANPC1LMNA
Isothiocyanate SCHEMBL25200912 0.93 AVPR1A (0.42) EPHX2AVPR1ARAB9ANPC1LMNA
SCHEMBL16802231 0.89 EPHX2 (0.48) EPHX2AVPR1ARAB9ANPC1LMNA
SCHEMBL23254197 0.84 EPHX2 (0.46) EPHX2AVPR1ALMNAHCRTR1HCRTR2
SCHEMBL16802089 0.82 EPHX2 (0.50) EPHX2AVPR1AHCRTR1HCRTR2TNKS
SCHEMBL16800078 0.82 EPHX2 (0.50) EPHX2AVPR1AHCRTR1HCRTR2TNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2370441-B1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES FOR USE AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2013-09-11 EP disclosed
US-8461152-B2 Arylcyclohexylethers of dihydrotetraazabenzoazulenes HOFFMANN-LA ROCHE INC. (US) 2013-06-11 US disclosed
US-20120225865-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES SCHNIDER PATRICK (CH) 2012-09-06 US disclosed
US-8227458-B2 Arylcyclohexylethers of dihydrotetraazabenzoazulenes HOFFMANN-LA ROCHE INC. (US) 2012-07-24 US disclosed
EP-2370441-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES FOR USE AS VASOPRESSIN VIA RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2011-10-05 EP disclosed
WO-2010060836-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES FOR USE AS VASOPRESSIN VIA RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2010-06-03 WO disclosed
US-20100137286-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES HOFFMANN-LA ROCHE, INC. 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120225865-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES AVPR1A, AVPR1B, AVPR2 EPHX2 3294/4885AVPR1A 1/4885RAB9A 441/4885
US-20100137286-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES AVPR1A, AVPR1B, AVPR2 EPHX2 3294/4885AVPR1A 1/4885RAB9A 441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.